These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1461600)

  • 1. Fenoterol: enough is enough.
    Garrett JE; Lanes S; Kolbe J; Rea HH
    N Z Med J; 1992 Oct; 105(943):414. PubMed ID: 1461600
    [No Abstract]   [Full Text] [Related]  

  • 2. Matching or selection bias in the fenoterol studies?
    Lanes SF
    N Z Med J; 1992 Oct; 105(943):413-4. PubMed ID: 1461599
    [No Abstract]   [Full Text] [Related]  

  • 3. Fenoterol: the evidence leading to restriction of it use.
    Elwood JM
    N Z Med J; 1990 Aug; 103(896):395-7. PubMed ID: 2200989
    [No Abstract]   [Full Text] [Related]  

  • 4. Fenoterol and asthma mortality in New Zealand.
    Pearce N; Crane J; Burgess C; Grainger J; Beasley R
    N Z Med J; 1990 Feb; 103(884):73-5. PubMed ID: 2308729
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of beta agonists and the risk of death and near death from asthma.
    Pearce N
    J Clin Epidemiol; 2009 Jun; 62(6):582-7. PubMed ID: 19422997
    [No Abstract]   [Full Text] [Related]  

  • 6. Baseline risk for asthma death.
    Garrett J; Lanes SF
    N Z Med J; 1992 Aug; 105(939):319. PubMed ID: 1472236
    [No Abstract]   [Full Text] [Related]  

  • 7. Fenoterol, asthma deaths, and asthma severity: confounding or confusion?
    Pearce N; Burgess C; Crane J; Beasley R
    Thorax; 1997 Aug; 52(8):750-1. PubMed ID: 9337841
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: "Confounding by indication and channeling over time: the risks of beta2-agonists".
    Pearce N; Beasley R; Crane J; Burgess C
    Am J Epidemiol; 1997 Nov; 146(10):885-7. PubMed ID: 9384211
    [No Abstract]   [Full Text] [Related]  

  • 9. Confounding by severity does not explain the association between fenoterol and asthma death.
    Beasley R; Burgess C; Pearce N; Woodman K; Crane J
    Clin Exp Allergy; 1994 Jul; 24(7):660-8. PubMed ID: 7953948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenoterol: confounding again.
    Pearce N; Grainger J; Beasley R; Crane J; Burgess C
    N Z Med J; 1989 Nov; 102(880):619. PubMed ID: 2636875
    [No Abstract]   [Full Text] [Related]  

  • 11. Fenoterol and asthma mortality.
    Crane J; Pearce N; Burgess C; Beasley R
    N Z Med J; 1990 May; 103(889):225. PubMed ID: 2342700
    [No Abstract]   [Full Text] [Related]  

  • 12. Fenoterol and asthma mortality.
    Kremer G; Disse B
    Lancet; 1998 Aug; 352(9126):485-6. PubMed ID: 9708779
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescribing of fenoterol and severity of asthma.
    Sears MR
    N Z Med J; 1990 Jan; 103(882):21-2. PubMed ID: 2304676
    [No Abstract]   [Full Text] [Related]  

  • 14. The saga of the New Zealand asthma mortality epidemic.
    N Z Med J; 1995 Mar; 108(995):91. PubMed ID: 7661939
    [No Abstract]   [Full Text] [Related]  

  • 15. Fenoterol and asthma mortality.
    Lipworth B; Jackson C
    Lancet; 1998 Aug; 352(9126):486-7. PubMed ID: 9708780
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of severe life threatening asthma.
    Barnes NC; Kuitert LM
    Thorax; 1996 Nov; 51(11):1073. PubMed ID: 8958886
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study.
    Grainger J; Woodman K; Pearce N; Crane J; Burgess C; Keane A; Beasley R
    Thorax; 1991 Feb; 46(2):105-11. PubMed ID: 2014490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End of New Zealand asthma epidemic.
    Westendorp RG; Blauw GJ
    Lancet; 1995 Apr; 345(8955):985. PubMed ID: 7715312
    [No Abstract]   [Full Text] [Related]  

  • 19. Fenoterol and asthma deaths in New Zealand.
    Grant IW
    N Z Med J; 1990 Apr; 103(887):160-1. PubMed ID: 2342677
    [No Abstract]   [Full Text] [Related]  

  • 20. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.
    Beasley R; Pearce N; Crane J; Burgess C
    Int Arch Allergy Immunol; 1995; 107(1-3):325-7. PubMed ID: 7613161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.